Molecular Characterization of Extended Spectrum β-Lactamase-Producing Escherichia coli: Insights into the O25b-ST131 Clone in Mexican Urinary Tract Infections
Jundishapur Journal of Microbiology · 06.03.2024 · 17 (2)
DOI: 10.5812/jjm-143352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Jundishapur Journal of Microbiology, online erschienen am 06.03.2024. Verfasst von Patricia Vargas-Gutierrez und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The urgent need for antimicrobial research to address the escalating global challenge of β-lactam antibiotic resistance, particularly in Escherichia coli-induced urinary tract infections (UTI), is underscored by the increasing resistance to ciprofloxacin in Latin America. This issue has led to a heightened dependence on alternative therapeutics, such as cephalosporins. The identification of extended-spectrum β-lactamase (ESBL)-producing E. coli, notably the O25b-ST131 clone, adds complexity to UTI management. The prevalence of ESBL-producing E. coli varies globally due to factors including regional antimicrobial usage practices.
Objectives
The goal of this study was to identify and molecularly characterize ESBL-producing E. coli isolates to identify the pandemic O25b-ST131 clone related to UTIs in one healthcare institution in Mexico.
Methods
Bacterial species identification and antibiotic susceptibility tests were performed using the VITEK 2. The ESBL genes were identified using polymerase chain reaction (PCR). The E. coli genotyping was carried out by the phylogenetic group analysis and the O25b-ST131 identification.
Results
A total of 86 unique E. coli isolates were confirmed as ESBL, and 75% were obtained from UTIs. The most prevalent β-lactamase genes were blaCTX-M (66%), blaTEM (8.1%), blaCTX-M/SHV (5.8%), blaCTX-M/TEM (4.6%), and blaSHV (2.3%). The B2 phylogroup was most prominent (54.4%), with 46.5% identified as a globally pandemic O25b-ST131 clone. No evident relationship was observed using random amplified polymorphic DNA (RAPD) between nosocomial and community-acquired infections in ESBL-producing E. coli isolates.
Conclusions
The obtained findings highlight the significance of monitoring molecular epidemiology in antibiotic resistance profiles of the O25b-ST131 E. coli clone.
Zitieren
APA
Vargas-Gutierrez, P., Silva-Sanchez, J., Uribe-Salas, F. J., Lopez-Jasso, F., Juarez-Perez, E. Y., Gonzalez-Martinez, M. D. R., & Camacho, H. B. (2024). Molecular Characterization of Extended Spectrum β-Lactamase-Producing Escherichia coli: Insights into the O25b-ST131 Clone in Mexican Urinary Tract Infections. Jundishapur Journal of Microbiology, 17(2). https://doi.org/10.5812/jjm-143352
Vancouver
Vargas-Gutierrez P, Silva-Sanchez J, Uribe-Salas FJ, Lopez-Jasso F, Juarez-Perez EY, Gonzalez-Martinez MDR, et al. Molecular Characterization of Extended Spectrum β-Lactamase-Producing Escherichia coli: Insights into the O25b-ST131 Clone in Mexican Urinary Tract Infections. Jundishapur Journal of Microbiology. 2024;17(2). doi:10.5812/jjm-143352
BibTeX
@article{VargasGutierrez2024,
author = {Vargas-Gutierrez, Patricia and Silva-Sanchez, Jesus and Uribe-Salas, Felipe Javier and Lopez-Jasso, Federico and Juarez-Perez, Evelyn Yveth and Gonzalez-Martinez, Marisela del Rocio and Camacho, Humberto Barrios},
title = {Molecular Characterization of Extended Spectrum β-Lactamase-Producing Escherichia coli: Insights into the O25b-ST131 Clone in Mexican Urinary Tract Infections},
journal = {Jundishapur Journal of Microbiology},
year = {2024},
volume = {17},
number = {2},
doi = {10.5812/jjm-143352}
}
EUVIMED